Need a mesothelioma lawyer? We will fight for you!
› $150,000,000 verdict in personal injury case
Three lawsuits against the makers of Fosamax, a popular medication to prevent bone loss, are slated to go to trial, including one filed in Alabama state court by Beasley Allen attorney W. Chad Cook. The lawsuits are among the nearly 900 cases brought against Merck & Co. by 1,280 plaintiff groups who allege Fosamax caused them serious jaw problems.
A science and health publisher says years ago it published what appeared to be medical journals for a group of Australian doctors that heavily favored Merck and Co.’s drugs Fosamax and Vioxx. The journals didn’t list who paid for the publishing, when in fact the publications were sponsored by Merck.
Back in January we explained how many pharmaceutical companies, following a Hollywood business model, have started to experience an erosion of their profits as patents expire on their “blockbuster” drugs. Aggressive, multi-billion-dollar marketing campaigns lead to multi-billion-dollar drug sales, but when patents expire, so do profits.
The Los Angeles Times on Sunday examined how the business “strategy that has made the pharmaceutical industry one of the wealthiest and most powerful on Earth” might have begun to “betray it.”
![[ Beasley Allen Law Firm Logo ]](http://www.fosamax-legal.com/wp-content/themes/system-unity/images/logo.png){kind=logo}